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Abstract
Group B streptococcus (GBS) is the main cause of neonatal sepsis and meningitis. Bacterial surface proteins play a major role
in GBS binding to and invasion of different host surfaces. The scpB and lmb genes, coding for fibronectin-binding and
laminin-binding surface proteins, are present in almost all human GBS isolates. The scpB-lmb intergenic region is a hot spot
for integration of two mobile genetic elements (MGEs): the insertion element IS1548 or the group II intron GBSi1. We
studied the structure of scpB-lmb intergenic region in 111 GBS isolates belonging to the intraspecies major clonal complexes
(CCs). IS1548 was mostly found (72.2%) in CC19 serotype III strains recovered more specifically (92.3%) from neonatal
meningitis. GBSi1 was principally found (70.6%) in CC17 strains, mostly (94.4%) of serotype III, but also (15.7%) in CC19
strains, mostly (87.5%) of serotype II. No MGE was found in most strains of the other CCs (76.0%), notably CC23, CC10 and
CC1. Twenty-six strains representing these three genetic configurations were selected to investigate the transcription and
expression levels of scpB and lmb genes. Quantitative RT-PCR showed that lmb transcripts were 5.0- to 9.6-fold higher in the
group of strains with IS1548 than in the other two groups of strains (P,0.001). Accordingly, the binding ability to laminin
was 3.8- to 6.6-fold higher in these strains (P#0.001). Moreover, Lmb amount expressed on the cell surface was 2.4- to 2.7-
fold greater in these strains (P,0.001). By contrast, scpB transcript levels and fibronectin binding ability were similar in the
three groups of strains. Deletion of the IS1548 sequence between scpB and lmb genes in a CC19 serotype III GBS strain
substantially reduced the transcription of lmb gene (13.5-fold), the binding ability to laminin (6.2-fold), and the expression of
Lmb protein (5.0-fold). These data highlight the importance of MGEs in bacterial virulence and demonstrate the up-
regulation of lmb gene by IS1548; the increased lmb gene expression observed in CC19 serotype III strains with IS1548 may
play a role in their ability to cause neonatal meningitis and endocarditis.
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Introduction
Streptococcus agalactiae (group B streptococcus [GBS]) is an important
human and bovine pathogen. It isthe most common agent of invasive
infections in neonates, causing pneumonia, septicemia and menin-
gitis, and is an increasingly common pathogen in adults [1,2]. GBS
species has been divided into phylogenetic lineages by a variety of
techniques among which multilocus sequence typing (MLST) has
become the standard method [3,4,5]. The presence in GBS genome
of mobile genetic elements (MGEs) suggests that horizontal genetic
transfer may play an important role in genome diversification and in
the emergence of virulent clones [6,7,8]. It has been demonstrated
that GBS diseases are mostly caused by a limited set of clonal lineages
[3,9,10,11] and that several MGEs are genetic markers for particular
genetic lineages. Indeed, clonal complex (CC) 17 appears to be
strongly able to invade the central nervous system (CNS) of neonates
and is marked by the group II intron GBSi1, whereas CC19 causes
infections among both neonates and adults and is marked by the
insertion sequence IS1548 [12,13]. This might reflect differences in a
number of fitness or virulence factors including the expression of
adhesins that have not been studied yet.
Genes encoding the surface proteins ScpB and Lmb are located
on a composite transposon [14]. Three different structures of the
scpB-lmb intergenic region are described (Fig. 1) since this region
appears to be a hot spot for integration that may contain the two
types of MGEs above-mentioned, GBSi1 or IS1548
[13,15,16,17,18]. GBSi1 and IS1548 are located 97-bp upstream
and 9-bp upstream of the putative promoter of the lmb gene,
respectively [17]. In addition to cleavage of the chemotactic
complement component C5a, ScpB mediates GBS binding to
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present in the extracellular matrix in a fibrillar form [19]; ScpB
also plays a role in the invasion of GBS into epithelial cells [20],
and an induced transcription of scpB by components of human
serum has recently been reported [21]. Binding of GBS to human
laminin, a major glycoprotein of the basement membrane [22], is
mediated by the surface-associated lipoprotein Lmb (laminin-
binding protein) [23]. Lmb shows homology to members of the
LraI family that includes Lsp/Lbp of Streptococcus pyogenes
[23,24,25] and it promotes GBS invasion into human brain
microvascular endothelial cells [26]. It has not been explored yet if
the presence of MGEs in scpB-lmb intergenic region correlates with
particular levels of transcription and expression of lmb and scpB
genes.
In this study, we analyzed the genetic diversity of the scpB-lmb
intergenic region in a collection of 111 GBS isolates belonging to
the major phylogenetic lineages. Strains representing the three
genetic configurations found were selected to determine the level
of transcription of lmb and scpB genes, the ability of strains to bind
to human laminin and fibronectin, and the Lmb expression on the
bacterial cell surface. We found that i) the structural diversity of
the scpB-lmb intergenic region was related to particular GBS
lineages ii) MGE presence had no influence on scpB gene
expression and iii) lmb gene transcription and expression were
significantly higher in strains possessing IS1548 between scpB and
lmb genes. We then constructed an IS1548 deleted mutant, and by
comparing its properties to those of the wild type parent strain, we
demonstrated the role of IS1548 on the up-regulation of lmb gene.
Results
Distribution of GBSi1 and IS1548 in GBS isolates
PCR was performed to characterize the region between scpB
and lmb genes in the 111 GBS clinical isolates, using a forward
primer at the 39end of scpB gene (scpB3382) and a reverse primer at
the 59end of lmb gene (rlmb51) (Fig. 1). A 400-bp product indicated
the lack of any insert in the spacer region. A 2,200-bp and a 1,600-
bp product were obtained in the presence of GBSi1 and of IS1548,
respectively. The presence of GBSi1 and IS1548 were then
confirmed using primer sets scpB3382/rGBSi143 and scpB3382/
rIS1548, respectively (Fig. 1). GBSi1 was found in 51 (45.9%)
strains, IS1548 was found in 18 (16.2%) strains, and none of the
two MGEs was observed in 40 (36.0%) isolates and in NEM316
strain. For two strains (V4 and G8) and for DscpB-lmb NEM316
mutant [14], no amplicons were obtained, and the absence of
amplification with primer sets scpB99/rscpB238 and lmb76/rlmb193
indicated that these strains lacked scpB and lmb genes.
Relationship between MLST genetic lineage, clinical
origin, distribution of MGEs, and capsular serotype
The 111 isolates were resolved into 40 sequence types (STs), and
clonal complexes (CCs) including isolates sharing six or seven
identical alleles were defined. The major CCs were CC17 (34.2%),
CC19 (18.9%), CC10 (13.6%), and CC23 (10.8%). A relationship
between clonal complexes and isolates clinical origin was observed:
28/38 (73.7%) of the CC17 strains and 16/21 (76.2%) of the
CC19 strains were recovered from invasive infections of neonates,
whereas 7/12 (58.3%) of the CC23 strains and 36/40 (90.0%) of
the strains of other CCs were recovered from gastric fluid of
colonized asymptomatic neonates and from vaginal swabs of
pregnant asymptomatic women. The structure of scpB-lmb
intergenic region was related to the distribution of strains in
clonal complexes (Table 1): 36/38 (94.7%) of the CC17 strains
had GBSi1 and 11/12 (91.7%) of the CC23 strains had no MGE;
in CC19, 13/21 strains (61.9%) had IS1548 and the other 8 strains
(38.1%) had GBSi1. Of the 13 CC19 strains carrying IS1548,1 2
(92.3%) originated from invasive infections (Table 2). Finally,
70.6% of the strains that had GBSi1 belonged to CC17 and 72.2%
of the strains that had IS1548 belonged to CC19 (Table 1); all
Figure 1. Genomic organization of the scpB-lmb intergenic
region. Dark grey box represents the noncoding spacer region. Primer
set scpB3382/rlmb51 was used to determine the structure of the scpB-
lmb intergenic region. The presence of the insertion sequence IS1548
and of the group II intron GBSi1 in the spacer was then confirmed using
primer sets scpB3382/r1S1548, and scpB3382/rGBSi143.
doi:10.1371/journal.pone.0010794.g001
Table 1. Distribution of 109 GBS strains according to the structure of scpB-lmb intergenic region and according to clonal
complexes as determined by MLST.
Clonal complexes (CC)
Nu of strains CC17 CC19 CC23 CC10 CC7 CC1 Other CC
Nu (%) Nu (%) Nu (%) Nu (%) Nu (%) Nu (%) Nu (%)
n=109 n=38 n=21 n=12 n=15 n=6 n=7 n=10
Without MGE 40 2 (5.0) 0 (0.0) 11 (27.5) 11 (27.5) 6 (15.0) 5 (12.5) 5 (12.5)
GBSi1 51 36 (70.6) 8 (15.7) 1 (2.0) 2 (3.9) 0 (0.0) 2 (3.9) 2 (3.9)
IS1548 18 0 (0.0) 13 (72.2) 0 (0.0) 2 (11.1) 0 (0.0) 0 (0.0) 3 (16.7)
doi:10.1371/journal.pone.0010794.t001
IS1548, lmb Activation, GBS
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capsular serotype III (Table 2). On the contrary, seven of the eight
strains (87.5%) from CC19 that had GBSi1 were of capsular
serotype II (Table 2). The distribution of the 40 strains that had no
MGE in the scpB-lmb intergenic region was various with 27.5%
from CC23, 27.5% from CC10, 15.0% from CC7, 12.5% from
CC1, only 5.0% from CC17 and none of them from CC19. A
great diversity of capsular serotypes was observed among the
strains lacking MGEs with notably 32.5% serotype Ia, mostly from
CC23, 25% serotype Ib, mostly from CC10, 12.5% serotype III,
and 12.5% serotype II strains.
Quantification of scpB and lmb transcripts
In order to investigate if the presence of GBSi1 and IS1548 in
scpB-lmb intergenic region affected the transcription of scpB and lmb
genes, 26 strains representing the three genetic configurations of
the various phylogenetic lineages were selected among the 111
isolates: nine strains had GBSi1 and were from CC17 (3 strains),
CC19 (5 strains) and CC1 (1 strain); nine strains had IS1548 and
were from CC19 (4 strains), CC10 (2 strains) and three singleton
STs (3 strains); eight strains had no MGE and were from CC23 (3
strains), CC10 (3 strains) and CC1 (2 strains). Transcription levels
were determined by real time PCR as detailed in Material and
Methods. In NEM316 deleted mutant (DscpB-lmb) and in V4 strain
that both lack the scpB and lmb genes, no transcripts were detected.
Figure 2A shows the mean levels of specific gene transcripts in
relation to the structure of the scpB-lmb intergenic region. The
three groups of strains revealed similar transcript levels of scpB
gene (P=0.96), indicating that the scpB gene transcription was not
dependant on the intergenic region pattern. On the contrary, the
mean transcription level of lmb gene in the group of strains with
IS1548 was 5.0- to 9.6-fold higher than that of the groups of
strains with GBSi1 and without MGE in scpB-lmb intergenic
region, respectively, (P,0.001 as determined with Kruskal-Wallis
test and Dunn’s Method for pairwise multiple comparison). The
transcription level of lmb gene was not related to the phylogeny of
strains but to the structure of scpB-lmb intergenic region. Indeed, as
shown in Table 3, for the nine CC19 strains studied, the mean
transcription level of lmb gene was 0.8660.69 for the five strains
having GBSi1, and 2.6961.34 for the four strains having IS1548.
Similarly, for the five CC10 strains studied, the mean transcription
level of lmb gene was 0.1960.16 for the three strains without
MGE, and 2.1760.34 for the two strains having IS1548. In the
groups of strains with GBSi1 and without MGE, the transcription
levels of scpB and lmb genes were similar (Fig. 2A). By contrast, in
strains harbouring IS1548, the transcription level of lmb gene was
significantly higher than that of scpB gene (P=0.001).
Binding of GBS strains to immobilized human fibronectin
and laminin
In order to analyze if the expression of scpB and lmb genes was
correlated with the level of transcription, we tested the ability of
the 26 GBS strains to bind to human fibronectin and to human
laminin (Fig. 2B). No difference between the fibronectin binding
ability of the three groups of strains was observed (P=0.86). By
contrast, strains with IS1548 bound significantly more strongly to
laminin (14.13%610.55%) than strains that had GBSi1
(2.14%61.13%) and strains without MGE in the scpB-lmb
intergenic region (3.70%61.78%) (P#0.001 as determined with
Kruskal-Wallis test and Dunn’s Method for pairwise multiple
comparison). The mean binding ability to human laminin of
strains with IS1548 was thus 3.8- to 6.6-fold increased as
compared with strains without MGE and with GBSi1, respective-
ly. As observed for the transcription level of lmb gene, the binding
ability to laminin was not related to the phylogenetic lineages of
strains, but to the structure of scpB-lmb intergenic region. Indeed,
as shown in Table 3, for the nine CC19 strains studied, the mean
binding ability to laminin was 2.60%61.06% for the five strains
having GBSi1, and 9.36%62.25% for the four strains having
IS1548. Similarly, for the five CC10 strains studied, the mean
binding ability to laminin was 2.52%61.10% for the three strains
without MGE, and 12.8466.74% for the two strains having
IS1548.
Quantification of Lmb on bacterial cell surface
To further analyze if the stronger binding ability to laminin of
strains with IS1548 was in relation with a stronger expression of
the laminin binding protein Lmb, quantification of Lmb on the
bacterial surfaces of the 26 GBS strains was performed in an
ELISA-type assay using polyclonal rabbit antibodies raised against
Lmb. Preimmune rabbit serum did not react with GBS strains. As
depicted in Fig. 3, the amount of Lmb was 2.4- to 2.7-fold
increased in GBS isolates with IS1548 as compared with the GBS
strains with GBSi1 or without MGE in scpB-lmb region,
respectively (P,0.001 as determined by ANOVA with Fisher’s
post-hoc test). These findings support our results of lmb transcripts
quantification and of binding ability of strains to laminin and point
out the association of IS1548 with the induction of lmb gene
expression.
Properties of the isogenic IS1548 deleted strain
In order to determine whether the up-regulation of the lmb gene
is caused by the upstream copy of IS1548, we deleted the IS1548
sequence between scpB and lmb genes in the genome of ST-19
serotype III L29 strain. The successful deletion was confirmed by
DNA sequencing of a 1.2 kb-PCR product obtained with
Table 2. Mobile genetic elements (MGEs) in scpB-lmb
intergenic region of CC17, CC19, CC23, and CC10 GBS strains









17 Ia 1 GBSi1 1 0
III 34 GBSi1 27 7
III 1 no MGE 0 1
NT
a 1 GBSi1 0 1
NT 1 no MGE 0 1
19 II 7 GBSi1 4 3
III 13 IS1548 12 1
NT 1 GBSi1 0 1
23 Ia 10 no MGE 4 6
Ia 1 GBSi1 0 1
III 1 no MGE 1 0
10 Ib 8 no MGE 1 7
Ib 1 GBSi1 0 1
II 3 no MGE 0 3
II 1 GBSi1 0 1
II 2 IS1548 02
aNT: not typeable.
doi:10.1371/journal.pone.0010794.t002
IS1548, lmb Activation, GBS
PLoS ONE | www.plosone.org 3 May 2010 | Volume 5 | Issue 5 | e10794scpB2987/rlmb497 primer set (data not shown). L29 wild type (WT)
strain and the isogenic mutant (DIS1548) were subsequently tested
for transcription of lmb gene by quantitative RT-PCR, expression
of Lmb protein on cell surface by ELISA and Western blot, and
binding ability to laminin. As depicted in Fig. 4, the isogenic
mutant showed a 13.5-fold decreased level of lmb transcripts, a 6.2-
Figure 2. Properties of 26 GBS isolates in relation to the scpB-lmb intergenic region structure (8 strains without MGE, 9 strains with
GBSi1 and 9 strains with IS1548). (A) Relative transcription levels of scpB (filled boxes) and lmb (open boxes) genes. The amount of transcripts of
each gene was normalized to the amount of gyrA transcripts and expressed relative to the level of transcription in L19 GBS isolate that has no MGE.
Boxes are means and bars are standard deviation of the means of the relative level of transcription in each group of strains. ** The mean transcription
level of lmb gene was significantly higher in the group of strains with IS1548 than in the other two groups of strains (P,0.001). (B) Binding ability of
GBS isolates to immobilized human fibronectin (filled boxes) and to immobilized human laminin (open boxes). Boxes are means and bars are
standard deviation of the means of the fibronectin and laminin binding percentages in each group of strains. ** The mean binding ability to laminin
was significantly higher in the group of strains with IS1548 than in the other two groups of strains (P#0.001).
doi:10.1371/journal.pone.0010794.g002
IS1548, lmb Activation, GBS
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Lmb protein amount as determined by ELISA, as compared to the
WT strain. Similarly, detection of Lmb protein by Western
blotting (Fig. 5) showed a decreased expression in L29DIS1548 as
compared to the WT strain.
Discussion
Mobile genetic elements are an important source of genetic
plasticity in prokaryotes. They drive bacterial evolution and
adaptation via recombination and horizontal transfer and they
influence the virulence of bacteria by modulating gene expression
[27]. ScpB and Lmb are two ubiquitous proteins localized at the
surface of GBS cells, and are thus good candidates for a GBS
vaccine. Therefore, it is of importance to better explore their
expression level, especially on account of the genetic diversity of S.
agalactiae species that is composed of multiple major phylogenetic
lineages. In line with this, we screened a large collection of strains
representing the diversity of the species for the presence of two
MGEs, GBSi1 and IS1548, between scpB and lmb genes, and
studied the expression of scpB and lmb genes for each scpB-lmb
intergenic region pattern. Moreover, we examined the effect of
deleting the upstream IS1548 copy on lmb gene expression in one
GBS isolate.
In our collection of 111 strains, only two strains lacked the
scpB and lmb genes, a result in accordance with previous data
that had revealed that almost all human isolates contained the
scpB and lmb genes, whereas these genes were absent in a
majority of strains of bovine origin [14,15,16,28]. Therefore,
our results reinforce the hypothesis that scpB-lmb region may be
essential for the colonization or infection in humans [14,21]. As
previously reported, we found a mutual exclusiveness of IS1548
and GBSi1 [9,12,17], and a diversity of patterns of the
intergenic region in relation to several major GBS lineages:
CC17 was characterized by GBSi1 and CC19 was characterized
by IS1548, while CC23 lacked GBSi1 and IS1548 [8,12,13,29].
Nevertheless, the CC19 strains clustered into two groups: all the
serotype III strains had IS1548 and all the serotype II strains
had GBSi1. Therefore, as previously suggested [9,30], these two
clusters seem to form distinct and relatively homogeneous
lineages that could have notable differences in virulence factors
expression.
Our different experimental approaches demonstrated that the
presence of GBSi1 or IS1548, which are located downstream of
the scpB gene, did not modify scpB transcription and expression. By
contrast, IS1548 was associated with an enhanced expression of
the lmb gene which resulted in a 5.0- to 9.6-fold increased lmb
transcription, a 3.8- to 6.6-fold increased binding ability to human
laminin, and a 2.4- to 2.7-fold increased expression of Lmb protein
on the bacterial cell surface, as compared to strains without MGE
or with GBSi1. These variations were independent of the
phylogenetic position of strains indicating that the lmb gene
expression was probably directly affected by the IS element
acquisition rather than by other genetic events linked to the
emergence of particular intraspecies clones. This hypothesis was
then demonstrated by construction of an IS1548 deleted mutant
which showed a 13.5-fold decreased transcription of lmb gene, a
5.0-fold decreased expression of Lmb protein, and a 6.2-fold
reduced binding ability to laminin, as compared to the parent
strain. Gene activation following integration of IS elements is a
well-known phenomenon, notably described for antibiotic resis-
tance, bacterial metabolism and virulence [31,32,33,34,35].
Several mechanisms could explain the role of IS1548 in the up-
regulation of the lmb gene. First, it could result from the provision
of an efficient promoter, carried either entirely by the IS element,
or generated as a hybrid structure between IS and the target
sequence. Indeed, in Lactococcus lactis, a hybrid promoter composed
of a 235 sequence located at the right end of an IS-like element,
and a 210 sequence located in the region adjacent to the element,
Table 3. lmb gene expression in 14 strains from two
phylogenetic lineages in relation to the presence of the
IS1548 sequence upstream lmb gene.
CC19 CC10
IS1548 + IS1548 2 IS1548 + IS1548 2
n=4 n=5 n=2 n=3
lmb gene transcripts
a 2.6961.34 0.8660.69 2.1760.34 0.1960.16
Laminin binding (%)
b 9.3662.25 2.6061.06 12.8466.74 2.5261.10
Lmb protein expression
c 6.0162.70 2.5060.70 4.8061.50 1.4560.20
almb gene transcripts were quantified by real time RT-PCR. The amount of lmb
transcripts was normalized to the amount of gyrA transcripts and expressed
relative to the level of transcription in L19 GBS isolate that has no MGE.
bThe percentage of binding to immobilized human laminin was obtained by
the ratio between the number of bound bacteria and the number of bacteria
present in the inoculum.
cLmb protein expressed at the bacterial cell surface was quantified in an ELISA-
type assay, as described in Figure 3.
doi:10.1371/journal.pone.0010794.t003
Figure 3. Expression of Lmb protein on GBS cells in relation to
the scpB-lmb intergenic region structure. Lmb protein was
quantified in an ELISA-type assay. GBS cells (8 strains without MGE, 9
strains with GBSi1, 9 strains with IS1548), were immobilized in microtiter
wells and incubated with rabbit anti-Lmb antibodies. Binding of
antibodies to the Lmb protein was quantified by addition of
peroxidase-conjugated goat anti-rabbit IgG, and subsequent addition
of OPD peroxidase substrate. Boxes are means and bars are standard
deviation of the means of the absorbance at 492 nm (A492) per
adhering bacteria in each group of strains. ** The amount of Lmb
protein was significantly higher in the group of strains with IS1548 as
compared with the other two groups of strains (P,0.001).
doi:10.1371/journal.pone.0010794.g003
IS1548, lmb Activation, GBS
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the citQRP operon involved in the transport of citrate [32].
Additionally, in Salmonella enterica serovar Typhimurium, new
promoter sequences were created by the integration of the IS1
element upstream of the original promoter for the multidrug efflux
acrEF operon, therefore providing an alternative promoter which
activated its expression [33]. The up-regulation of the lmb gene
could also result from the disruption or displacement of a repressor
binding site following the insertion of IS1548 upstream of lmb
gene, thus leading to the increase of lmb expression. This
mechanism was suggested to explain the activation of the
endogenous Bacteroides fragilis cephalosporinase gene, cepA,b y
IS1224 [34]. Additional studies are needed to explore these
mechanisms.
Genes encoding GBS surface and secreted proteins constitute
potentially useful virulence factors to explain the ability of GBS to
invade the central nervous system (CNS) of neonates. Several studies
have reported that a particular allelic form of gbs2018, srr-2,a n dfbsB
genes encoding peptidoglycan anchored and fibrinogen-binding
proteins were specific of the highly virulent ST-17 clone [28,36,37],
mostly prevalent in neonatal meningitis [5,13], but no specific factors
appeared to be related to the other virulent clonal complexes,
especially to CC19 that was regularly described in neonatal
meningitis. We have recently reported that 100% of the CC17
Figure 4. Properties of L29 wild type GBS strain and isogenic IS1548 deletion mutant. Relative transcription levels of lmb gene, binding
ability of GBS cells to immobilized human laminin, and expression of Lmb protein on GBS cells as determined by ELISA, in an isogenic mutant deleted
for IS1548 sequence between scpB and lmb genes (L29DIS1548) (striped boxes) as compared to the parent strain (L29 WT) (open boxes). Each
experiment was performed at least three times. Boxes are means and bars are standard deviation of the means.
doi:10.1371/journal.pone.0010794.g004
Figure 5. Detection of Lmb protein by Western blot in L29 wild type GBS strain and isogenic IS1548 deletion mutants. 10 mg of total
bacterial cell proteins isolated from strains 1: NEM316 (no MGE), 2: DscpB-lmb NEM316 mutant, 3: L29 wild type (IS1548), 4 to 7: four independent
L29DIS1548 mutant strains were separated by SDS PAGE and transferred to an Immobilon P polyvinylidene difluoride membrane. The blots were
probed with rabbit anti-Lmb antibodies that were detected with a horseradish peroxidase labeled secondary anti-rabbit antibody that was then
visualized by the ECL system (Amersham Biosciences). Molecular sizes in kDa are depicted at the left.
doi:10.1371/journal.pone.0010794.g005
IS1548, lmb Activation, GBS
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strains thatpossessed bothfbsA and fbsB fibrinogen-binding genes and
had the highest ability to bind to human fibrinogen [38]; nearly all
these strains had GBSi1 in the scpB-lmb intergenic region, a
configuration that does not increase lmb expression. By contrast, we
have previously found that 84.0% of the CC19 strains studied here
were devoid of the fbsB gene sensu stricto and had a truncated form of
the fbsA gene leading to a low fibrinogen binding ability [38].
Therefore, contrarily to CC17 strains, the fibrinogen binding ability
does not appear as a major factor to explain the ability of CC19
strains to invade neonatal CNS. Interestingly, 13 of the 21 CC19
strains (61.9%) had IS1548 in the scpB-lmb intergenic region and had
consequently an increased binding ability to laminin, and 12 of these
13 CC19 IS1548 positive isolates were recovered from CNS. It was
previously demonstrated that FbsA and Lmb proteins are important
factors for GBS adherence to and invasion into the blood-brain
barrier that facilitates the entry of the bacteria into the cerebrospinal
fluid [26,39]. Therefore, we may hypothesize that the two fibrinogen
binding genes fbsA and fbsB promote the ability of CC17 strains to
invade CNS of neonates whereas the enhanced expression of lmb
gene due to IS1548 promotes that of CC19 isolates.Similarly,IS1548
was identified in the hyaluronidase gene hylB of S. agalactiae
endocarditis isolates [40]. In such strains, an additional copy of
IS1548 was always found downstream of the scpBgene [40,41,42]. As
streptococci colonize cardiac valves with pre-existing endothelial
lesions that lead to the exposure of underlying basement membrane
structures [43], the enhancement of GBS adhesion to basement
membrane laminin may be critical for the bacterial colonization of
damaged epithelium and endothelium.
In summary, our results support the importance of transposable
elements in bacterial virulence. We demonstrated that IS1548
strongly activates lmb gene expression. This might explain the
particular ability of some S. agalactiae strains, mostly belonging to
CC19 and to capsular serotype III, to invade the CNS of neonates.
Further studies are needed to clarify the mechanisms explaining the
overexpression of lmb gene by IS1548 in these particular strains.
Materials and Methods
Bacterial strains and growth conditions
A total of 111 unrelated human strains representing the genetic
diversity of Streptococcus agalactiae species were included in the
present study: 54 strains from the cerebrospinal fluid of infected
neonates, 21 strains from the gastric fluid of colonized asymp-
tomatic neonates and 36 strains from vaginal swabs of colonized
asymptomatic pregnant women. Strains were isolated between
1986 and 1990 from 25 general hospitals throughout France [11].
Neonatal specimens were obtained from infected neonates
suffering of meningitis and from non infected neonates with risk
factor, and vaginal specimens were obtained from asymptomatic
pregnant women during the process of routine clinical diagnostic
procedures, as part of the usual prenatal and postnatal screening.
All data were analyzed anonymously. According to the informa-
tion we obtained from the Institutional Review Board (more than
20 years ago), this type of study did not require an ethics approval
and the patient consent. All strains had previously been serotyped
on the basis of capsular polysaccharides [11]. Six serotypes were
identified i.e. serotypes Ia (16 strains), Ib (12 strains), II (17 strains),
III (55 strains), IV (3 strains), and V (3 strains), and five strains
were not typeable. S. agalactiae wild-type NEM316, and an isogenic
scpB-lmb mutant of NEM316, which comprises a deletion of the
complete scpB-lmb composite transposon structure (DscpB-lmb) were
used as control strains. The strain was generated by insertion of a
pG
+host5 plasmid [44] into the lmb gene of NEM316, and
subsequent mobilization of the plasmid as described by Franken
et al. [14].
GBS strains were stored at 280uC in Schaedler-vitamin K3
broth (bioMe ´rieux, Marcy l’Etoile, France) with 10% glycerol.
The bacteria were grown for 24 h on 5% horse blood Trypticase
soja (TS) agar plates (bioMe ´rieux) at 37uC.
Escherichia coli DH5a was used for cloning purposes. It was
grown at 37uC in Luria Broth. E. coli and GBS clones carrying the
pG
+host5 plasmid were selected in the presence of 300 mg/ml and
2 mg/ml erythromycin, respectively.
Construction of an IS1548 deletion mutant
The IS1548 sequence was deleted in the chromosome of ST-19
serotype III L29GBS strain by a method adapted from that described
by Schubert et al. [45]. Briefly, a DNA fragment including 421 bp at
the 39 end of scpB gene, the whole scpB-lmb intergenic region, and
400 bp at the 59 end of lmb gene was amplified by PCR with the
primer pair IS1548_del1 59-CCGCGGATCCGGCCACTCTAA-
TAAGCCAGAA and IS1548_del2 59-GGGGGTACCAAT-
GCCTTGTGTGACTTCCA from the genome of ST-23 serotype
III V27 GBS strain that harbors no MGE in this region. The BamHI
restriction site of IS1548_del1 and the KpnI restriction site of
IS1548_del2 are underlined. The resulting PCR product and the
thermosensitive vector pG
+host5 [44] were digested with BamHI and
KpnI, ligated, and transformed into E. coli DH5a. The resulting
plasmid pG
+IS1548neg was electroporated into S. agalactiae L29 [46],
and transformants were grown at 28uC with erythromycin selection.
Cells in which pG
+IS1548neg h a di n t e g r a t e di n t ot h ec h r o m o s o m e
were selected at 37uC under erythromycin pressure. Four of such
clones were serially passaged for 6 days in Todd-Hewitt (TH) broth
(Sigma, St Quentin Fallavier, France) at 28uC without erythromycin
pressure to facilitate the excision of plasmid pG
+IS1548neg,l e a v i n g
the desired IS1548 deletion in the chromosome. Dilutions of the
serially passaged cultures were plated onto TS agar plates, and single
colonies were tested for erythromycin sensitivity to identify
pG
+IS1548neg excisants. Successful deletion of IS1548 sequence
was confirmed by PCR using scpB2987/rlmb497 primer set (Table 4)
and by sequencing the amplified fragment.
Table 4. Oligonucleotide primers.
Name of
primer Sequence (59-39) Target sequence
scpB3382 TTATGACCACTTTCTTCTTGGGA scpB-lmb intergenic region
rlmb51 CTATCATTACTAAACTCACAAC
scpB2987 AATGGAAGGCGCTACTGTTC scpB-lmb intergenic region
rlmb497 GGATCCAAACGTCCTAGCTC
scpB3382 TTATGACCACTTTCTTCTTGGGA IS1548 in scpB-lmb
intergenic region
rIS1548 CTTCATCCTTTTGTGCCCGGACATC
scpB3382 TTATGACCACTTTCTTCTTGGGA GBSi1 in scpB-lmb
intergenic region
rGBSi143 CTCCATTTCCTCATCGTCAG
lmb76 CCCAAACAGCCTACGCAAG lmb gene
rlmb193 TGCCTGCACCTGATTGGATC
scpB99 TGTGACAGAAGACACTCCTG scpB gene
rscpB238 CGTCATCTGCTACTGTTTCTCC
gyrA CGGGACACGTACAGGCTACT gyrA gene
rgyrA CGATACGAGAAGCTCCCACA
doi:10.1371/journal.pone.0010794.t004
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All primers used (Table 4) were purchased from Eurogentec
(Seraing, Belgium). Bacterial genomic DNA extracted and purified
by conventional methods [47] was used as the template for PCR
assays. PCR was carried out with 0.5 U Taq DNA polymerase
(Roche Diagnostics, Mannheim, Germany) with an initial 5 min
hold at 94uC followed by 30 cycles of amplification steps of 1 min
at 94uC, 0.5 min at 55uC, and 2 min at 72uC, followed by a final
10 min step at 72uC.
Quantification of specific transcripts with real-time PCR
S. agalactiae strains were grown overnight in 50 ml of TH broth
to stationary growth phase ([OD595]=1.2). Bacterial cells pelleted
by centrifugation were lysed mechanically with 0.25–0.5 mm glass
beads (Sigma) in Tissue Lyser (Qiagen, Hilden, Germany) for
6 min at 30 Hz. RNA was purified by using the RNeasy Mini kit
(Qiagen), then treated with DNase using DNAfree kit (Ambion,
Cambridgeshire, UK) and checked for DNA contamination by
PCR amplification without prior reverse transcription. As no
amplicons were obtained, the possibility of DNA contamination
during RNA preparation could be excluded. Reverse transcription
of 1 mg of RNA was performed with random hexanucleotides and
the Quantiscript Reverse Transcription kit (Qiagen). Real-time
quantitative PCR was performed in a 25 ml reaction volume
containing cDNA (50 ng), 12.5 ml QuantiTect SYBR Green PCR
Master Mix (Qiagen), and 0.3 mM of each gene-specific primer in
an iCycler iQ detection system (BioRad). The specific primers for
gyrA, lmb and scpB genes listed in Table 4 were used. The PCR
consisted of an initial 15 min hold at 95uC followed by 40 cycles,
each of 15 sec at 94uC, 30 sec at 58uC, and 30 sec with
fluorescence acquisition at 72uC. The specificity of the amplified
product was verified by generating a melting-curve with a final
step of 50 cycles of 10 sec at an initial temperature of 70uC,
increasing 0.5uC each cycle up to 95uC. The quantity of cDNA for
the investigated genes was normalized to the quantity of gyrA
cDNA in each sample. The gyrA gene was chosen as an internal
standard since gyrase genes represent ubiquitously expressed
house-keeping genes that are frequently used for the normalization
of gene expression in quantitative reverse transcription-PCR
experiments [48,49]. The transcription levels of scpB and lmb genes
in the GBS isolate L19 which has no MGE in the scpB-lmb
intergenic region, were treated as the basal levels. Each
experiment was performed at least three times.
Binding of GBS to immobilized human fibronectin and
human laminin
All binding assays were performed in triplicate. Flat bottomed
96-well polystyrene plates (Ciblex, Ivry sur Seine, France) were
coated for 18 h at room temperature with 10 mg/ml human
plasma fibronectin (Sigma) or with 10 mg/ml human placenta
laminin purified by immunoaffinity chromatography (Sigma)
diluted in phosphate-buffered saline (PBS) (150 mM NaCl,
10 mM sodium phosphate buffer, pH 7.2). Bacterial cells were
harvested from overnight cultures in TH broth and resuspended in
PBS. Laminin- and fibronectin-coated wells were washed, and
then 50 ml of PBS containing 1610
5 to 1610
6 CFU per ml were
added to each well. After incubation for 90 min at 37uC, non
binding bacteria were removed by washing with PBS. Bound
bacteria were subsequently unbound by the addition of a 0.01%
solution of protease/serine protease mix (Sigma) to each well as
previously described [38], then the viable bacteria were quantified
by plating serial dilutions onto TS agar plates. The percentage of
binding to human laminin and fibronectin was obtained by the
ratio between the number of bound bacteria and the number of
bacteria present in the inoculum.
Quantification of Lmb protein on bacterial cells by ELISA
Quantification of Lmb was determined in an ELISA-type assay.
Flat bottomed 96-well polystyrene plates were coated overnight at
4uC with GBS cells grown to stationary phase (5610
5 CFU/well).
After washing with PBS, the wells were treated for 1 h at room
temperature with 2% bovine serum albumin in PBS in order to block
additional protein binding sites. The wells were washed with 0.05%
T w e e n2 0i nP B Sa n di n c u b a t e d1ha t3 7 uC with polyclonal rabbit
anti-Lmb antibodies which were raised against Lmb recombinant
protein [23], or with rabbit preimmune serum at a dilution of 1:200.
The absence of reactivity of preimmune serum and the specificity of
anti-Lmb antibodies towards Lmb protein were previously shown
[23], and the ability of anti-Lmb antibodies to inhibit bacterial
binding to laminin was demonstrated [26]. After washing, wells were
incubated for 1 h at 37uC with a peroxidase-conjugated goat anti-
rabbit IgG (Camarillo, CA, USA) at a dilution of 1:10,000. The
conjugated enzyme was allowed to react with o-phenylenediamine
dihydrochloride (OPD) (Sigma) and absorbance at 492 nm (A492)w a s
monitored with a microtiter plate reader (Labsystems iEMS Reader
MF, Labsystems, Helsinki, Finland). ELISA results were expressed as
A492 values divided by the number of bacteria that had adhered to
each well, as determined by crystal violet staining, a common method
used to quantify bacteria adhering to plastics, more particularly in
biofilms [50,51,52]: cells were stained with 100 ml0 . 3 %c r y s t a lv i o l e t
at room temperature for 15 min. Excess crystal violet was then
discarded and the wells were washed 3 times with water. Crystal
violet was then extracted from the cells by 200 ml absolute ethanol for
45 min at room temperature and transferred to a new microtiter
plate. The quantity of bacteria was estimated by measuring the A590
of each well using a microtiter plate reader.
Detection of Lmb protein by Western blot
Total bacterial cell protein was isolated from GBS strains as
previously described [53]. For each strain, 10 mg of protein was
separated on a 12% SDS polyacrylamide gel and transferred to an
Immobilon P polyvinylidene difluoride membrane. Following
preabsorption of the antibody with a an Lmb negative S. agalactiae
strain, the blots were probed with polyclonal rabbit anti-Lmb
antibodies [23] at a dilution of 1:200. For the detection of bound
primary antibody, a horseradish peroxidase labeled secondary
anti-rabbit antibody was used at a dilution of 1:8,000. Bound
secondary antibody was visualized by the ECL system (Amersham
Biosciences Europe, Freiburg, Germany) in accordance with
instructions provided by the manufacturer.
Multilocus sequence typing
The 111 strains were typed by multilocus sequence typing (MLST)
by sequencing ,500-bp fragments of seven housekeeping genes
(adhP, pheS, atr, glnA, sdha, glcK,a n dtkt) as described by Jones et al. [5].
Nucleotide sequences were compared with those available on the
MLST database (http://pubmlst.org/sagalactiae/). After assigning
an allele number to each locus, the sequence type (ST) which takes in
account the allele combination of the seven loci was determined for
each isolate. Clonal complexes including isolates sharing six or seven
identical alleles were defined.
Statistical analysis
Data were analyzed using one-way analysis of variance
(ANOVA) with Fisher’s post-hoc test. When conditions of
normality were not met to use parametric analysis, a non-
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comparison procedures (Dunn’s Method) was used to find
statistical differences between results. Statistically significant
difference was determined at 95% confidence level. Parametric
tests were carried out with Minitab version 10.51 (MINITAB Inc.,
State College, PA, USA) and non-parametric tests with SigmaStat
version 2.03 (Systat Software Inc., Richmond, CA, USA).
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